109 related articles for article (PubMed ID: 6891504)
1. Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.
Griffiths BE; Hughes P; Dowdle R; Stephens MR
Thorax; 1982 Sep; 37(9):711-2. PubMed ID: 6891504
[No Abstract] [Full Text] [Related]
2. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Fedor JM; Stack RS; Pryor DB; Phillips HR
Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
[TBL] [Abstract][Full Text] [Related]
3. [Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].
Békés M; Cserhalmi L; Glavanov M; Csukás A; Szilágyi M; Huszár G
Med Welt; 1980 Sep; 31(39):1408-11. PubMed ID: 6450306
[No Abstract] [Full Text] [Related]
4. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
[TBL] [Abstract][Full Text] [Related]
5. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
[No Abstract] [Full Text] [Related]
6. Nifedipine in hypertrophic cardiomyopathy.
Pouleur H; Rousseau MF
Circulation; 1982 Aug; 66(2):478-9. PubMed ID: 7201360
[No Abstract] [Full Text] [Related]
7. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
[No Abstract] [Full Text] [Related]
8. [Nifedipine in hypertrophic obstructive cardiomyopathy].
Schanzenbächer P; Schick KD; Kochsiek K
Dtsch Med Wochenschr; 1982 Dec; 107(48):1842-6. PubMed ID: 6890438
[TBL] [Abstract][Full Text] [Related]
9. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Senn M; Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
[TBL] [Abstract][Full Text] [Related]
10. [Risks of beta-blockers and calcium inhibitors in amyloid cardiopathy].
Bouhour JB; Haddak M; Lefevre M
Presse Med; 1986 May; 15(21):981. PubMed ID: 2874550
[No Abstract] [Full Text] [Related]
11. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
Hopf R; Thomas J; Klepzig H; Kaltenbach M
Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
[TBL] [Abstract][Full Text] [Related]
13. Production of ischaemic cardiac pain by nifedipine.
Jariwalla AG; Anderson EG
Br Med J; 1978 May; 1(6121):1181-2. PubMed ID: 638679
[No Abstract] [Full Text] [Related]
14. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
[TBL] [Abstract][Full Text] [Related]
15. Unpredictable response to nifedipine in severe cardiac failure.
Brooks N; Cattell M; Pidgeon J; Balcon R
Br Med J; 1980 Nov; 281(6251):1324. PubMed ID: 7437785
[No Abstract] [Full Text] [Related]
16. Nifedipine and beta-blockade as a cause of cardiac failure.
Anastassiades C
Br Med J (Clin Res Ed); 1982 Feb; 284(6314):506. PubMed ID: 6120739
[No Abstract] [Full Text] [Related]
17. Cardiac amyloidosis. Therapeutic and diagnostic difficulties with reference to two different forms of the disease.
Leinonen H; Pohjola-Sintonen S
Acta Med Scand; 1986; 219(1):125-8. PubMed ID: 3953311
[TBL] [Abstract][Full Text] [Related]
18. [Paradoxical effect of nifedipine. A case report].
Tirella G; Miloni G; Zaninetti P
G Ital Cardiol; 1982; 12(2):161-3. PubMed ID: 7173544
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine and beta-blockade as a cause of cardiac failure.
Robson RH; Vishwanath MC
Br Med J (Clin Res Ed); 1982 Jan; 284(6309):104. PubMed ID: 6797645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
